Nature Medicine, Published online: 27 July 2026; doi:10.1038/s41591-026-04528-x
Longitudinal proteomic analysis of plasma from unaffected carriers of ALS-associated pathogenic variants revealed early protein changes before ALS symptoms and enabled mapping of their trajectories as well as prediction of the timing of phenoconversion